Advancements and future directions in research of the roles of insulin in amyloid diseases

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Amyloid diseases, such as type 2 diabetes, Alzheimer's disease and Parkinson's disease are characterized by amyloid aggregates. Insulin is released from the pancreas, and it is known that insulin downstream signaling molecules are located majorly in the regions of cortex and hippocampus. Therefore, insulin plays crucial roles not only in the pancreas, but also in the brain. Recent studies have focused on the role of insulin in amyloid diseases. This review demonstrates the recent studies in which insulin affects amyloid aggregation. Specifically, molecular modeling studies provide insights into the molecular mechanisms of the effects of insulin in amyloid aggregates. Still, experimental studies are required to provide insights into the kinetics effects. This review opens new avenues for future studies on insulin molecules and amyloid aggregation.

Original languageEnglish
Article number106720
JournalBiophysical Chemistry
StatePublished - 1 Feb 2022


  • Alzheimer's disease
  • Amyloid fibrils
  • Insulin
  • Parkinson's disease
  • Type 2 diabetes

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Organic Chemistry


Dive into the research topics of 'Advancements and future directions in research of the roles of insulin in amyloid diseases'. Together they form a unique fingerprint.

Cite this